TCTR20210731003招募中2 期
Immunogenicity and safety of the third dose COVID-19 vaccine via intradermal compare with intramuscular administration (Randomized controlled trial)
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 960
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. 18 years old or more 2. No history of a severe allergic reaction to the prior vaccine. 3. No fever nor history of fever within 14 days. 4. No symptoms of respiratory tract infection within 14 days. 5. Received two doses of COVID-19 vaccine for at least 3 months 6. sign informed consent to the study.
排除标准
- •1. pregnancy. 2. lactation.
研究者
相似试验
招募中
2 期
Immunogenicity and safety of the third dose COVID-19 vaccine in Thai population.After the third dose of the COVID-19 vaccine, the immune response in healthy volunteers who received 2 doses of COVID19 vaccine (CoronaVac or ChAdOx1) at least three months.COVID-19 vaccine, Third dose, ChAdOx1, coronavac, Sinovac, BNT162b2, SinopharmTCTR20210731004Chulabhorn Royal Academy5,520
Unknown
3 期
Safety and immunogenicity of the third COVID-19 vaccines booster dose in children (12-18 years) with completed 2 doses as recommended by the ministry of public healthHealth adolescentsCOVID-19, booster, vaccineTCTR20221215006Chulalongkorn University320
进行中（未招募）
不适用
Immunogenicity of the 3rd COVID-19 vaccine dose in Thai healthcare workers at Bamrasnaradura Infectious Diseases InstituteHealthcare workers who received two doses of SinovacCOVID-19 VaccineSARS-CoV-2AntibodyHealthcare WorkersAstraZenecaPfizerTCTR20211005001ational Research Council of Thailand (NRCT)170
已完成
Unknown
Immune response to a third COVID-19 vaccine dose in people with multiple sclerosis receiving B cell-depleting therapyImmunosuppressionCOVID-19 vaccinationNeurological - Multiple sclerosisInfection - Other infectious diseasesMultiple SclerosisACTRN12623001249640Royal Adelaide Hospital53
招募中
不适用
Pattern of antibody response after 3rd dose of COVID-19 vaccine booster among healthy volunteers.Healthy volunteerCOVID-19 Vaccinesadministration and dosageimmunologyTCTR20210831002akornping Hospital180